Powerful choices: Peer support and individualized medication self-determination

Schizophrenia Bulletin

Volumn 37, Issue 3, 2011, Pages 445-450

  West, Corinna ^a  

^a Mental Health America of the Heartland   (United States)

Author keywords

dopamine supersensitivity psychosis; evidence based practices; recovery; self advocacy; shared decision making; social connection

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT;

ARTICLE; BICYCLE; DECISION MAKING; EVIDENCE BASED PRACTICE; HUMAN; INFORMED CONSENT; MENTAL DISEASE; MENTAL HEALTH CARE; OLFACTORY HALLUCINATION; PEER GROUP; PRIORITY JOURNAL; RUNNING; SCHIZOPHRENIA; SELF CONCEPT; SUPPORT GROUP; VISUAL HALLUCINATION; WALKING;

CHOICE BEHAVIOR; HUMANS; INDIVIDUALIZED MEDICINE; MENTAL DISORDERS; MENTAL HEALTH SERVICES; PEER GROUP; PERSONAL AUTONOMY; PSYCHIATRY; SOCIAL SUPPORT;

EID: 79955435812     PISSN: 05867614     EISSN: 17451701     Source Type: Journal    
DOI: 10.1093/schbul/sbp053     Document Type: Article

References (30)

1. Missouri Department of Mental Health, Office of Transformation. http://www.dmh.missouri.gov/transformation/ transformation.htm. AccessedMarch 5, 2009.
2. Deegan PE. The importance of personal medicine: a qualitative study of resilience in people with psychiatric disabilities. Scand J Public Health Suppl. 2005;66:29-35.
3. Missouri Bicycle Federation. http://mobikefed.org/2005/09/ how-many-missourians-are-non-drivers.php. Accessed March 4, 2009.
4. Peebles SA, Mabe PA, Davidson L, Fricks L, Buckley PF, Fenley G. Recovery and systems transformation for schizophrenia. Psychiatr Clin North Am. 2007;30:567-583. (Pubitemid 47299147)
5. Paulson R, Herinckx H, Demmler J, Clarke G, Cutler D, Birecree E. Comparing practice patterns of consumer and non-consumer mental health service providers. Community Ment Health J. 1999;35:251-269. (Pubitemid 29291587)
6. Sells D, Black R, Dabidson L, Rowe M. Beyond generic support: incidence and impact of invalidation in peer services for clients with severe mental illness. Psychiatr Serv. 2008;59:1322-1327.
7. SMDL #07-011, U.S. Centers of Medicare and Medicaid Services, August 15, 2007. http://www.cms.hhs.gov. Accessed March 4, 2009.
8. Eiken S, Campbell J. Medicaid coverage of peer support for people with mental illness: available research and state examples. Thompson Reuters Healthcare Report. Washington, DC: Centers for Medicare & Medicaid Services (CMS); 2008.
9. Gates LB, Akabas SH. Developing strategies to integrate peer providers into the staff of mental health agencies. Adm Policy Ment Health. 2007;34:293-306. (Pubitemid 46742595)
10. Deegan P. Recovery as a journey of the heart. Psychiatr Rehabil J. 1996;19:91-97.
11. Crowley K. The Power of Procovery. Los Angeles, CA: Kennedy Carlisle Publishing; 2000:19.
12. Fisher DB, Ahern L. Evidence-based practices and recovery. Psychiatr Serv. 2002;53:632-633.
13. Roe D, Swarbrick M. A recovery-oriented approach to psychiatric medication. J Psychosoc Nurs Ment Health Serv. 2007; 5:35-40.
14. Geddes J, Freemantle N, Harrison P, Bebbington P. Atypical antipsychotics in the treatment of schizophrenia: systematic overview and meta-regression analysis. BMJ. 2000;321: 1371-1376.
15. Frese FJ, Stanley J, Kress K, Vogel-Scibilia S. Integrating evidence based practices and the recovery model. Psychiatr Serv. 2001;52:1462-1468. (Pubitemid 33029584)
16. Carey B. Revisiting schizophrenia: are drugs always needed? New York Times. March 21, 2006. Quoting Will Hall. http:// www.nytimes.com/2006/03/21/ health/psychology/21schiz.html?- r=1#. Accessed May 19, 2009.
17. Bola JR, Mosher LR. Clashing ideologies or scientific discourse. Schizophr Bull. 2002;28:583-588.
18. Harding CM, Zahniser JH. Empirical correction of seven myths about schizophrenia with implications for treatment. Acta Psychiatr Scand Suppl. 1994;384:140-146. (Pubitemid 24356900)
19. Harrow M, Jobe TH. Factors involved in outcome and recovery in schizophrenia patients not on antipsychotic medications. J Nerv Ment Dis. 2007;195:406-414. (Pubitemid 46763242)
20. Beasley CM, Sutton VK, Taylor CC, Sethuraman G, Dossenbach M, Naber D. Is quality of life among minimally symptomatic patients with schizophrenia better following withdrawal or continuation of antipsychotic treatment? J Clin Psychopharmacol. 2006;26:40-44. (Pubitemid 43167089)
21. Viguera AC, Baldessarini RJ, Hegarty JD, van Kammen DP, Tohen M. Clinical risk following abrupt and gradual withdrawal of maintenance neuroleptic treatment. Arch Gen Psychiatry. 1997;54:49-55. (Pubitemid 27044698)
22. Moncrieff J. Does antipsychotic withdrawal provoke psychosis? Review of the literature on rapid onset psychosis (supersensitivity psychosis) and withdrawal-related relapse. Acta Psychiatr Scand. 2006;114:3-13. (Pubitemid 43885479)
23. Seeman P, Weinshenker D, Quirion R, et al. Dopamine supersensitivity correlates with D2high states, implying many paths to psychosis. Proc Natl Acad Sci U S A. 2005;102:3513-3518. (Pubitemid 40328076)
24. Seeman P, Schwarz J, Chen JF, et al. Psychosis pathways converge via D2high dopamine receptors. Synapse. 2006;60: 319-346. (Pubitemid 44134353)
25. Samaha AN, Seeman P, Stewart J, Rajabi H, Kapur S. ''Breakthrough'' dopamine supersensitivity during ongoing antipsychotic treatment leads to treatment failure over time. J Neurosci. 2007;27:2979-2986. (Pubitemid 46438984)
26. Chouinard G, Chouinard VA. Atypical antipsychotics: CATIE study, drug induced movement disorder and resulting iatrogenic psychiatric-like symptoms, supersensitivity rebound psychosis and withdrawal discontinuation syndromes. Psychother Psychosom. 2008;77:69-77. (Pubitemid 351172096)
27. Kurihara T, Kato M, Reverger R, Yagi G. Clinical outcome of patients with schizophrenia without maintenance treatment in a nonindustrialized society. Schizophr Bull. 2002;28:515-524. (Pubitemid 36193869)
28. Whitaker R. The case against antipsychotic drugs: a 50-year record of doing more harm than good. Med Hypotheses. 2004; 62:5-13. (Pubitemid 38199998)
29. Bollini P, Pampallona S, Neiddu S, Bianco M, Tibaldi G, Munizza C. Indicators of conformance with guidelines of schizophrenia treatment in mental health services. Psychiatr Serv. 2008;59:782-791.
30. Luchins DJ. Letter. Psychiatr Serv. 2006;57:139-140.